According to the technical analyst, the IT index is expected to consolidate between 30,600 - 26,300 range.
The broader trend in Bajaj Finance and Bajaj Finserv stocks has turned weak and if both these stocks fail to rebound overcoming key levels, the sell-off could intensify.
18,125 will trigger some strength for bulls on Nifty50 index whereas the expected targets would be 18,180 - 18,225 - 18,300
The derivative analyst from HDFC Securities expects Glenmark Pharma January futues to test Rs 450 on the upside.
According to the technical analyst from Anand Rathi, HDFC Life can jump to Rs 660; while ICICI Prudential Life can rally to Rs 510.
PVR and Inox Leisure stocks must defend key levels to avoid turning bearish, show technical charts
On the upside, the technical analyst sees 18,336 as the key resistance for the Nifty 50.
On the downside, MCX Crude Oil January futures could slide to Rs 5,940 or even re-test the recent lows at Rs 5,850-level; Natural Gas seems on course to test Rs 290 level.
The technical analyst expects Nifty to test 18,336 and 18,464 on the upside; whereas Bank Nifty needs to surpass 43,860 for fresh buys, Nathani suggests.
On the broader market outlook, the technical & derivative analyst from HDFC Securities suggests that the trend for Nifty is still bearish.
According to the technical analyst from Anand Rathi, Linde India can rally to Rs 3,875; while Saregama can surge to Rs 425.
The derivative analyst from HDFC Securities recommends to Buy Bharat Forge 880 Call and simultaneously Sell 900 Call for the January expiry.
According to the technical analyst from Anand Rathi, Metro Brands can rally to Rs 910; while Bayer Cropscience can surge to Rs 5,200.
On the downside, key support for MCX Crude Oil stands at Rs 6,350, below which a steeper fall to Rs 4,800 seems possible. Rs 413 - 418 is the resistance zone for Natural Gas on Wednesday.
Among individual stocks, the technical & derivative analyst from HDFC Securities recommends buying RCF and NCC.
The stellar performance of sugar stocks began in 2021, and is likely to continue in the new year - 2023, indicates the technical charts.
According to the technical analyst from Anand Rathi, ABB can advance to Rs 2,880; while MRPL can jump to Rs 57.
Technically, the Nifty Pharma index needs to immediate hurdle at 13,500, for further upside to 14,250.
The options data indicates that the Nifty may look to hold on the 18,000-mark till expiry, given the high OI at the 18,000 Put.
According to the technical analyst from Anand Rathi, Aurobindo Pharma can rally to Rs 490; while Biocon can jump to Rs 295.